Interleukin-1β and Risk of Premature Death in Patients With Myocardial Infarction

Inhibition of the interleukin (IL)-1β innate immunity pathway is associated with anti-inflammatory effects and a reduced risk of recurrent cardiovascular events in stable patients with previous myocardial infarction (MI) and elevated high-sensitivity C-reactive protein (hs-CRP). This study assessed...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2020-10, Vol.76 (15), p.1763-1773
Hauptverfasser:	Silvain, Johanne, Kerneis, Mathieu, Zeitouni, Michel, Lattuca, Benoit, Galier, Sophie, Brugier, Delphine, Mertens, Emilie, Procopi, Niki, Suc, Gaspard, Salloum, Tomy, Frisdal, Eric, Le Goff, Wilfried, Collet, Jean-Philippe, Vicaut, Eric, Lesnik, Philippe, Montalescot, Gilles, Guerin, Maryse
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biomarkers - blood C-reactive protein Coronary Angiography Female Follow-Up Studies France - epidemiology Humans inflammation Interleukin-18 - blood interleukin-1β Life Sciences Male Middle Aged mortality Mortality, Premature - trends myocardial infarction Myocardial Infarction - blood Myocardial Infarction - diagnosis Myocardial Infarction - mortality Prospective Studies Risk Assessment - methods Risk Factors Survival Rate - trends
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!